This study also shows that LITAF contributes to the increase in TNF-α secretion in macrophages from inflamed colonic tissue and highlight a potential value of anti-LITAF strategies for the therapeutic management of inflammatory conditions known to be associated with TNF-α such as IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.